Bisker-Leib Vered's Form 4 filing
Compass Therapeutics, Inc. (CMPX) · filed Nov 25, 2022
- Accession no.
- 0001171843-22-007662
- Filed
- Nov 25, 2022
- Trade date
- Nov 22-25, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $103.7K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bisker-Leib VeredCIK 0001814093 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2022 | Common Stock | SSaleDisposed | −14,929 | $4.19 | −$62,552.51 | 1,069,985 | Direct | |
| Nov 23, 2022 | Common Stock | SSaleDisposed | −9,569 | $4.30 | −$41,146.7 | 1,060,416 | Direct | |
| Nov 25, 2022 | Common Stock | SSaleDisposed | −2 | $4.36 | −$8.72 | 1,060,414 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.